Applied DNA Sciences Schedules Fiscal First Quarter Webcast for February 10, 2015 at 9:00 AM EST

STONY BROOK, NY--(Marketwired - January 27, 2015) - Applied DNA Sciences (NASDAQ: APDN), (Twitter: @APDN), a provider of DNA-based anti-counterfeiting technology and product authentication solutions, will host a conference call on Tuesday, February 10, 2015 at 9:00 AM EST to discuss its fiscal first quarter results. The Quarterly Report Form 10Q will be filed with the SEC by the end of the day on Monday, February 9, 2015, and the press release will be issued prior to the call.

Dr. James Hayward, President and CEO, and Karol Kain Gray, CFO of Applied DNA Sciences, plan to discuss the company's performance and achievements and outline key ongoing and future business initiatives. The presentation will be followed by a question-and-answer session.

All participants must pre-register for the webcast using the link below. It is suggested that you log into the webcast approximately 10 minutes prior to the scheduled start time to ensure that all participants are on-line at the start of the call. While callers cannot be heard during the call, questions may be emailed beforehand to investor@adnas.com.

For those investors unable to participate in the call, a copy of the presentation is expected to be posted by end of business on February 10, 2015, and available under the "Investors" tab of the company's web site.

To Participate:

Reserve your Webinar seat now at: https://attendee.gotowebinar.com/register/5821523006886945281

To send questions prior to the call: Please email questions prior to the call to investor@adnas.com.

Due to the large number of expected participants, not all questions may be answered on the call.

We make life real and safe by providing botanical-DNA based security and authentication solutions and services that can help protect products, brands, entire supply chains, and intellectual property of companies, governments and consumers from theft, counterfeiting, fraud and diversion. SigNature® DNA describes the platform ingredient that is at the heart of all of our security and authentication solutions. SigNature DNA is at the core of a family of uncopyable products such as DNAnet®, our anti-theft product, SigNature® T, targeted toward textiles, and digitalDNA®, providing powerful track and trace. All provide a forensic chain of evidence and can be used to prosecute perpetrators.

Applied DNA Sciences is listed on the NASDAQ under the symbol APDN, and its warrants are listed under the symbol APDNW. The statements made by APDN in this press release may be "forward-looking" in nature within the meaning of the Private Securities Litigation Act of 1995. Forward-looking statements describe APDN's future plans, projections, strategies and expectations, and are based on assumptions and involve a number of risks and uncertainties, many of which are beyond the control of APDN. Actual results could differ materially from those projected due to our short operating history, limited financial resources, limited market acceptance, market competition and various other factors detailed from time to time in APDN's SEC reports and filings, including our Annual Report on Form 10-K filed on December 15, 2014, which are available at www.sec.gov. APDN undertakes no obligation to update publicly any forward-looking statements to reflect new information, events or circumstances after the date hereof to reflect the occurrence of unanticipated events, unless otherwise required by law.